-
17
2020-11The Moderna vaccine is 94.5% effective against coronavirus, according to early data released Monday by the company, making it the second vaccine in the United States to have a stunningly high success -
12
2020-11Pfizer and BioNTech SE today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate again -
10
2020-11Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of -
06
2020-11The antiviral drug remdesivir, considered one of the most promising Covid-19 treatments, turns out to do little to prevent deaths from the disease, according to a WHO-backed study. -
06
2020-11Some Asian countries are rolling out early and more aggressive influenza vaccination programs this year, seeking to reduce the potential of people contracting the flu and COVID-19 simultaneously, crip -
06
2020-11Merck, known as MSD outside the United States and Canada, announced findings from two additional Phase 3 studies evaluating the safety, tolerability and immunogenicity of V114, the company’s investig··· -
06
2020-11New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against in -
05
2020-11Influenza vaccination may have a protective effect for COVID-19-positive patients, according to a brief report recently published in the Journal of the American Board of Family Medicine. -
19
2020-10The first study comparing the immune responses of adults and children with COVID-19 has detected key differences that may contribute to understanding why children usually have milder disease than adul -
19
2020-10The study of Johnson & Johnson’s Covid-19 vaccine has been paused due to an unexplained illness in a study participant. -
19
2020-10Pfizer is setting plans to make its coronavirus vaccine available to more groups of people, should the pharma company prove that the shot works to prevent the virus. -
27
2020-09Free human papillomavirus vaccinations will be provided to girls aged 13 to 14 and a half in Xiamen, Fujian province, until the end of 2022 to help prevent cervical cancer. -
27
2020-09A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children six to 23 mo -
27
2020-09A pneumococcal vaccine was effective at protecting children in Laos against the most severe type of pneumonia, a new study has found. -
27
2020-09French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their COVID-19 vaccine candidate to the Canadian government, which has already signed similar agreement